Your browser doesn't support javascript.
loading
HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel, L; Pujal, J M; Martínez-Yélamos, S; Gubieras, L; Matas, E; Bau, L; Torrabadella, M; Azqueta, C; Arbizu, T.
Afiliação
  • Romero-Pinel L; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Pujal JM; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Martínez-Yélamos S; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Gubieras L; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Matas E; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Bau L; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
  • Torrabadella M; Banc de cordó umbilical, Banc de sang i teixits, Barcelona, Spain.
  • Azqueta C; Banc de cordó umbilical, Banc de sang i teixits, Barcelona, Spain.
  • Arbizu T; Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL.
Eur J Neurol ; 18(2): 337-342, 2011 Feb.
Article em En | MEDLINE | ID: mdl-20629714
ABSTRACT
BACKGROUND AND

OBJECTIVE:

The association of HLA-DRB1*15 with susceptibility to multiple sclerosis (MS) has been consistently reported although its effect on the clinical phenotype is still controversial. The objectives of this study are to investigate the influence of the HLA-DRB1 alleles on the genetic susceptibility to MS and to study their impact on disability progression in a Spanish population.

METHODS:

HLA-DRB1 typing was performed by PCR-SSP in 380 patients with sporadic MS and 1088 unrelated healthy controls. Allelic frequencies were compared between groups. We studied the correlation between the different alleles and the progression of MS.

RESULTS:

The HLA-DRB1*15 allele in patients with MS had a statistically significant higher frequency when compared with controls (18.9% in patients vs. 10.1% in controls, Odds ratio (OR)=2.07, 95% CI=1.64-2.60, P<0.001). In the univariate analysis, the DRB1*01 and DRB1*04 alleles were associated with a worse prognosis when considering the time to reach an EDSS of 6, whereas the DRB1*03 was correlated with a better outcome. In the multivariate analysis, the alleles*01 and *04 were demonstrated to be independent factors to have a worse prognosis.

CONCLUSIONS:

HLA-DRB1*15 is associated with MS when comparing patients with unrelated healthy controls in a Spanish population. The HLA-DRB1*01 and HLA-DRB1*04 alleles are related to a worse prognosis when considering the time taken to reach severe disability.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HLA-DR / Predisposição Genética para Doença / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HLA-DR / Predisposição Genética para Doença / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2011 Tipo de documento: Article